Glenmark Pharmaceuticals Ltd

GLENMARK

Company Profile

  • Business description

    Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe, and the rest of the world.

  • Contact

    B. D. Sawant Marg
    Glenmark House
    Chakala, Off Western Express Highway
    Andheri (East)
    MumbaiMH400099
    IND

    T: +91 2240189999

    E: [email protected]

    https://www.glenmarkpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    16,287

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,175.1049.900.61%
CAC 407,536.2633.480.45%
DAX 4022,242.45177.940.81%
Dow JONES (US)40,113.5020.100.05%
FTSE 1008,415.257.810.09%
HKSE21,980.7470.980.32%
NASDAQ17,382.94216.901.26%
Nikkei 22535,705.74666.591.90%
NZX 50 Index12,017.8461.370.51%
S&P 5005,525.2140.440.74%
S&P/ASX 2007,968.2047.700.60%
SSE Composite Index3,295.062.23-0.07%

Market Movers